12th Annual Nantz National Alzheimer Center Symposium - LIVE (In-Person)
LIVE (In-Person) attendance (LIMITED SPACE AVAILABLE)
Presented by the Houston Methodist Neurological Institute
The Nantz National Alzheimer Center symposium will examine the current knowledge regarding dementia with Lewy bodies (DLB). DLB shares the same defining pathology as Parkinson's (Lewy body pathology) but is associated with a faster progression. DLB is the second most common neurodegenerative cause of dementia after Alzheimer's disease. Despite its prevalence, DLB is frequently not recognized and has been studied to a lesser extent than Parkinson's disease and Alzheimer's disease. Our program will cover multiple aspects of DLB. We will review the evolution and clinical features of dementia with Lewy bodies. A review of the differences in the pathology and comorbidities present in DLB will follow this presentation. The symposium will continue with a description of the genetic landscape in DLB and its relation to Alzheimer's disease and Parkinson's disease. Moving to diagnosis and prognosis, the subsequent two presentations will describe imaging, cerebrospinal fluid, and blood biomarker advances in this condition. The last two sections will review the clinical progression and the impact on caregivers, ending with an overview and challenges for clinical trial design in DLB.
FEES
REGISTRATION TYPE | FEE |
Internal (Houston Methodist) | |
Physician (Houston Methodist, HMPAQ member, or HMCC ACO PCP member) | Complimentary |
Other Health Care Professional | Complimentary |
External (Non-Houston Methodist) | |
Physician (Private physician located within the Greater Houston Area) | $210 |
Physician (Private physician located outside the Greater Houston Area) | Complimentary |
Other Health Care Professional | Complimentary |
Resident / Fellow / Student (No CME, internal/external) | Complimentary |
All Others | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
Physicians, scientists with an interest in neurobiology, neuropsychologists, speech pathologists, physician assistants, nurse practitioners, nurses, physical therapists, occupational therapists, social workers, residents and fellows
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Recognize the clinical signs and symptoms that define DLB
- Discuss the co-pathologies that are frequently present in DLB
- Identify the genetic correlates of DLB
- Identify the different clinical and research biomarkers and their differences
- Describe and recognize the impact of the progressive symptoms on caregivers
- Discuss the current and future landscape of clinical trials in DLB
TIME | PRESENTATION | SPEAKER |
7:30 AM | Registration and Breakfast | |
8:30 AM | Welcome | Stanley H. Appel, MD |
8:35 AM | Nantz Symposium Welcome | Jim Nantz, III |
8:40 AM | Nantz Symposium Overview | Joseph C. Masdeu, MD, PhD |
8:45 AM | Clinical Aspects of DLB and the Evolution of its Clinical Criteria | John-Paul Taylor, MD |
9:25 AM | Q & A Discussion | |
9:35 AM | DLB Neuropathology and Coincident Co-Pathologies | Jon B. Toledo, MD, PhD |
10:15 AM | Q & A Discussion | |
10:25 AM | BREAK | |
10:35 AM | Genetics of DLB | Sonja W. Scholz, MD, PhD |
11:15 AM | Q & A Discussion | |
11:25 AM | Imaging Biomarkers in DLB | Kejal Kantarci, MD |
12:05 PM | Q & A Discussion | |
12:20 PM | LUNCH | |
1:20 PM | Biofluid Biomarkers in DLB | Lynn Bekris, PhD |
2:00 PM | Q & A Discussion | |
2:10 PM | Clinical Progression in DLB and Effects on Patients and Caregivers | Melissa J. Armstrong, MD |
2:50 PM | Q & A Discussion | |
3:00 PM | BREAK | |
3:10 PM | Challenges and Opportunities in DLB Clinical Trials | James B. Leverenz, MD, PhD |
3:50 PM | Q & A Discussion | |
4:00 PM | Adjournment |
In-person attendance will be held in the John F. Bookout Auditorium, 2nd Floor, Houston Methodist Research Institute, 6670 Bertner Avenue.
COURSE DIRECTORS |
Joseph C. Masdeu MD, PhD |
Director, Nantz National Alzheimer Center Houston Methodist Stanley H. Appel Department of Neurology |
Jon B. Toledo, MD, PhD |
Assistant Professor, Houston Methodist Stanley H. Appel Department of Neurology Research Director, Nantz National Alzheimer Center |
GUEST FACULTY |
Melissa J. Armstrong, MD, MSc, FAAN |
Associate Professor, Department of Neurology Director, Mangurian Clinical-Research Headquarters for Lewy Body Dementia Norman Fixel Institute for Neurological Diseases Gainesville, Florida |
Lynn M. Bekris, MS, PhD |
Associate Professor of Molecular Medicine Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland, Ohio |
Kejal Kantarci, MD |
Professor of Radiology Neuroradiology Division, Department of Radiology Mayo Clinic Rochester Rochester, Minnesota |
James B. Leverenz, MD |
Director, Cleveland Clinic Lou Ruvo Center for Brain Health Cleveland Clinic Cleveland, Ohio |
Sonja W. Scholz, MD, PhD |
Lasker Clinical Research Scholar, Neurodegenerative Diseases Research Unit National Institute of Neurological Disorders and Stroke Bethesda, Maryland |
John-Paul Taylor, MD |
Professor of Translational Dementia Research with the Institute of Translational and Clinical Research Newcastle University Honorary Consultant in Old Age Psychiatry with the Cumbria, Northumberland, Tyne and Wear (NTW) NHS Trust United Kingdom |
HOUSTON METHODIST FACULTY |
Stanley H. Appel, MD |
Director, Ann Kimball & John W. Johnson Center for Cellular Therapeutics Houston Methodist Stanley H. Appel Department of Neurology |
Available Credit
- 6.00 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.00 ASETThis program has been approved for 6.00 ASET CEUs total. Partial credit is available to those participants unable to attend the entire program. Please be sure to sign in each day for credit.
- 6.00 Attendance
- 6.08 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award 6.08 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.
- 5.75 Occupational Therapy12th Annual Nantz National Alzheimer Center Symposium - LIVE (In-Person) is a TOTA Approved Course from Tue, 11/15/2022 - 9:30am to Fri, 03/17/2023 - 5:00pm
- 5.75 Physical TherapyThis activity has been approved by the Texas Board of Physical Therapy Examiners for 5.75 CCUs for PTs and PTAs.
Price
STEPS TO REGISTER:
- STEP 1 - Choose the appropriate fee and click the "Add to Cart" button to complete the checkout process.
- STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.
FEES
REGISTRATION TYPE | FEE |
Internal (Houston Methodist) | |
Physician (Houston Methodist, HMPAQ member, or HMCC ACO PCP member) | Complimentary |
Other Health Care Professional | Complimentary |
External (Non-Houston Methodist) | |
Physician (Private physician located within the Greater Houston Area) | $210 |
Physician (Private physician located outside the Greater Houston Area) | Complimentary |
Other Health Care Professional | Complimentary |
Resident / Fellow / Student (No CME, internal/external) | Complimentary |
All Others | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.